APO Research
Talk to an analyst

APO RESEARCH · REPORT

Medical Sevoflurane

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Medical Sevoflurane Industry Growth and Trends Forecast to 2032

27 December 202597 pages

Choose your research edition.

Industry ResearchMedical Sevoflurane Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Medical Sevoflurane Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Medical Sevoflurane Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Medical Sevoflurane Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Medical Sevoflurane Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Medical Sevoflurane market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Medical Sevoflurane is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Medical Sevoflurane is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Medical Sevoflurane is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Medical Sevoflurane include AbbVie, Maruishi, Piramal, PT Novell Pharmaceutical, Viatris, Baxter, Lunan Pharma and Hengrui, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Medical Sevoflurane market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Medical Sevoflurane market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Medical Sevoflurane market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Medical Sevoflurane.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Medical Sevoflurane market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Medical Sevoflurane Market by Company

AbbVie

Maruishi

Piramal

PT Novell Pharmaceutical

Viatris

Baxter

Lunan Pharma

Hengrui

Medical Sevoflurane Segment by Type

250ml/Bottle

120ml/Bottle

Other

Medical Sevoflurane Segment by Application

Children

Adults

Medical Sevoflurane Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Sevoflurane market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medical Sevoflurane and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Sevoflurane.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Medical Sevoflurane manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Medical Sevoflurane in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 250ml/Bottle Table 2. Major Company of 120ml/Bottle Table 3. Major Company of Other Table 4. Global Medical Sevoflurane Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Medical Sevoflurane Sales by Type (2021-2026) & (K Units) Table 6. Global Medical Sevoflurane Sales Market Share in Volume by Type (2021-2026) Table 7. Global Medical Sevoflurane Sales by Type (2021-2026) & (US$ Million) Table 8. Global Medical Sevoflurane Sales Market Share in Value by Type (2021-2026) Table 9. Global Medical Sevoflurane Price by Type (2021-2026) & (US$/Unit) Table 10. Global Medical Sevoflurane Sales by Type (2027-2032) & (K Units) Table 11. Global Medical Sevoflurane Sales Market Share in Volume by Type (2027-2032) Table 12. Global Medical Sevoflurane Sales by Type (2027-2032) & (US$ Million) Table 13. Global Medical Sevoflurane Sales Market Share in Value by Type (2027-2032) Table 14. Global Medical Sevoflurane Price by Type (2027-2032) & (US$/Unit) Table 15. North America Medical Sevoflurane Sales by Type (2021-2026) & (K Units) Table 16. North America Medical Sevoflurane Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Medical Sevoflurane Sales by Type (2021-2026) & (K Units) Table 18. Europe Medical Sevoflurane Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Medical Sevoflurane Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Medical Sevoflurane Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Medical Sevoflurane Sales by Type (2021-2026) & (K Units) Table 22. Latin America Medical Sevoflurane Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Medical Sevoflurane Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Medical Sevoflurane Sales by Type (2021-2026) & (US$ Million) Table 25. Medical Sevoflurane Industry Trends Table 26. Medical Sevoflurane Industry Drivers Table 27. Medical Sevoflurane Industry Opportunities and Challenges Table 28. Medical Sevoflurane Industry Restraints Table 29. Global Medical Sevoflurane Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Medical Sevoflurane Revenue Market Share by Company (2021-2026) Table 31. Global Medical Sevoflurane Sales by Company (2021-2026) & (K Units) Table 32. Global Medical Sevoflurane Sales Share by Company (2021-2026) Table 33. Global Medical Sevoflurane Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Medical Sevoflurane Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Medical Sevoflurane Major Company Production Sites and Headquarters Table 36. Global Medical Sevoflurane Company, Product Type & Application Table 37. Global Medical Sevoflurane Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Medical Sevoflurane by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Medical Sevoflurane Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Medical Sevoflurane Sales by Region (2021-2026) & (K Units) Table 42. Global Medical Sevoflurane Sales Market Share in Volume by Region (2021-2026) Table 43. Global Medical Sevoflurane Sales by Region (2021-2026) & (US$ Million) Table 44. Global Medical Sevoflurane Sales Market Share in Value by Region (2021-2026) Table 45. Global Medical Sevoflurane Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Medical Sevoflurane Sales by Region (2027-2032) & (K Units) Table 47. Global Medical Sevoflurane Sales Market Share in Volume by Region (2027-2032) Table 48. Global Medical Sevoflurane Sales by Region (2027-2032) & (US$ Million) Table 49. Global Medical Sevoflurane Sales Market Share in Value by Region (2027-2032) Table 50. Global Medical Sevoflurane Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Medical Sevoflurane Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Medical Sevoflurane Sales by Application (2021-2026) & (K Units) Table 53. Global Medical Sevoflurane Sales Market Share in Volume by Application (2021-2026) Table 54. Global Medical Sevoflurane Sales by Application (2021-2026) & (US$ Million) Table 55. Global Medical Sevoflurane Sales Market Share in Value by Application (2021-2026) Table 56. Global Medical Sevoflurane Price by Application (2021-2026) & (US$/Unit) Table 57. Global Medical Sevoflurane Sales by Application (2027-2032) & (K Units) Table 58. Global Medical Sevoflurane Sales Market Share in Volume by Application (2027-2032) Table 59. Global Medical Sevoflurane Sales by Application (2027-2032) & (US$ Million) Table 60. Global Medical Sevoflurane Sales Market Share in Value by Application (2027-2032) Table 61. Global Medical Sevoflurane Price by Application (2027-2032) & (US$/Unit) Table 62. North America Medical Sevoflurane Sales by Application (2021-2026) & (K Units) Table 63. North America Medical Sevoflurane Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Medical Sevoflurane Sales by Application (2021-2026) & (K Units) Table 65. Europe Medical Sevoflurane Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Medical Sevoflurane Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Medical Sevoflurane Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Medical Sevoflurane Sales by Application (2021-2026) & (K Units) Table 69. Latin America Medical Sevoflurane Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Medical Sevoflurane Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Medical Sevoflurane Sales by Application (2021-2026) & (US$ Million) Table 72. AbbVie Company Information Table 73. AbbVie Business Overview Table 74. AbbVie Medical Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. AbbVie Medical Sevoflurane Product Portfolio Table 76. AbbVie Recent Development Table 77. Maruishi Company Information Table 78. Maruishi Business Overview Table 79. Maruishi Medical Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Maruishi Medical Sevoflurane Product Portfolio Table 81. Maruishi Recent Development Table 82. Piramal Company Information Table 83. Piramal Business Overview Table 84. Piramal Medical Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Piramal Medical Sevoflurane Product Portfolio Table 86. Piramal Recent Development Table 87. PT Novell Pharmaceutical Company Information Table 88. PT Novell Pharmaceutical Business Overview Table 89. PT Novell Pharmaceutical Medical Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. PT Novell Pharmaceutical Medical Sevoflurane Product Portfolio Table 91. PT Novell Pharmaceutical Recent Development Table 92. Viatris Company Information Table 93. Viatris Business Overview Table 94. Viatris Medical Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Viatris Medical Sevoflurane Product Portfolio Table 96. Viatris Recent Development Table 97. Baxter Company Information Table 98. Baxter Business Overview Table 99. Baxter Medical Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Baxter Medical Sevoflurane Product Portfolio Table 101. Baxter Recent Development Table 102. Lunan Pharma Company Information Table 103. Lunan Pharma Business Overview Table 104. Lunan Pharma Medical Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Lunan Pharma Medical Sevoflurane Product Portfolio Table 106. Lunan Pharma Recent Development Table 107. Hengrui Company Information Table 108. Hengrui Business Overview Table 109. Hengrui Medical Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Hengrui Medical Sevoflurane Product Portfolio Table 111. Hengrui Recent Development Table 112. North America Medical Sevoflurane Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 113. North America Medical Sevoflurane Sales by Country (2021-2026) & (K Units) Table 114. North America Medical Sevoflurane Sales Market Share by Country (2021-2026) Table 115. North America Medical Sevoflurane Sales Forecast by Country (2027-2032) & (K Units) Table 116. North America Medical Sevoflurane Sales Market Share Forecast by Country (2027-2032) Table 117. North America Medical Sevoflurane Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. North America Medical Sevoflurane Market Size by Country (2021-2026) & (US$ Million) Table 119. North America Medical Sevoflurane Market Share by Country (2021-2026) Table 120. North America Medical Sevoflurane Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. North America Medical Sevoflurane Market Share Forecast by Country (2027-2032) Table 122. Europe Medical Sevoflurane Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 123. Europe Medical Sevoflurane Sales by Country (2021-2026) & (K Units) Table 124. Europe Medical Sevoflurane Sales Market Share by Country (2021-2026) Table 125. Europe Medical Sevoflurane Sales Forecast by Country (2027-2032) & (K Units) Table 126. Europe Medical Sevoflurane Sales Market Share Forecast by Country (2027-2032) Table 127. Europe Medical Sevoflurane Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Europe Medical Sevoflurane Market Size by Country (2021-2026) & (US$ Million) Table 129. Europe Medical Sevoflurane Market Share by Country (2021-2026) Table 130. Europe Medical Sevoflurane Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Europe Medical Sevoflurane Market Share Forecast by Country (2027-2032) Table 132. Asia-Pacific Medical Sevoflurane Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 133. Asia-Pacific Medical Sevoflurane Sales by Country (2021-2026) & (K Units) Table 134. Asia-Pacific Medical Sevoflurane Sales Market Share by Country (2021-2026) Table 135. Asia-Pacific Medical Sevoflurane Sales Forecast by Country (2027-2032) & (K Units) Table 136. Asia-Pacific Medical Sevoflurane Sales Market Share Forecast by Country (2027-2032) Table 137. Asia-Pacific Medical Sevoflurane Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Asia-Pacific Medical Sevoflurane Market Size by Country (2021-2026) & (US$ Million) Table 139. Asia-Pacific Medical Sevoflurane Market Share by Country (2021-2026) Table 140. Asia-Pacific Medical Sevoflurane Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Asia-Pacific Medical Sevoflurane Market Share Forecast by Country (2027-2032) Table 142. Latin America Medical Sevoflurane Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 143. Latin America Medical Sevoflurane Sales by Country (2021-2026) & (K Units) Table 144. Latin America Medical Sevoflurane Sales Market Share by Country (2021-2026) Table 145. Latin America Medical Sevoflurane Sales Forecast by Country (2027-2032) & (K Units) Table 146. Latin America Medical Sevoflurane Sales Market Share Forecast by Country (2027-2032) Table 147. Latin America Medical Sevoflurane Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Latin America Medical Sevoflurane Market Size by Country (2021-2026) & (US$ Million) Table 149. Latin America Medical Sevoflurane Market Share by Country (2021-2026) Table 150. Latin America Medical Sevoflurane Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Latin America Medical Sevoflurane Market Share Forecast by Country (2027-2032) Table 152. Middle East and Africa Medical Sevoflurane Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 153. Middle East and Africa Medical Sevoflurane Sales by Country (2021-2026) & (K Units) Table 154. Middle East and Africa Medical Sevoflurane Sales Market Share by Country (2021-2026) Table 155. Middle East and Africa Medical Sevoflurane Sales Forecast by Country (2027-2032) & (K Units) Table 156. Middle East and Africa Medical Sevoflurane Sales Market Share Forecast by Country (2027-2032) Table 157. Middle East and Africa Medical Sevoflurane Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Middle East and Africa Medical Sevoflurane Market Size by Country (2021-2026) & (US$ Million) Table 159. Middle East and Africa Medical Sevoflurane Market Share by Country (2021-2026) Table 160. Middle East and Africa Medical Sevoflurane Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Middle East and Africa Medical Sevoflurane Market Share Forecast by Country (2027-2032) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Medical Sevoflurane Distributors List Table 165. Medical Sevoflurane Customers List Table 166. Research Programs/Design for This Report Table 167. Authors List of This Report Table 168. Secondary Sources Table 169. Primary Sources List of Figures Figure 1. Medical Sevoflurane Image Figure 2. Global Medical Sevoflurane Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Medical Sevoflurane Market Size (2021-2032) & (US$ Million) Figure 4. Global Medical Sevoflurane Sales (2021-2032) & (K Units) Figure 5. 250ml/Bottle Image Figure 6. Global 250ml/Bottle Sales YoY Growth (2021-2032) & (K Units) Figure 7. 120ml/Bottle Image Figure 8. Global 120ml/Bottle Sales YoY Growth (2021-2032) & (K Units) Figure 9. Other Image Figure 10. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Medical Sevoflurane Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Medical Sevoflurane Market Share by Type 2025 VS 2032 Figure 13. North America Medical Sevoflurane Sales Market Share in Volume by Type in 2025 Figure 14. North America Medical Sevoflurane Sales Market Share in Value by Type in 2025 Figure 15. Europe Medical Sevoflurane Sales Market Share in Volume by Type in 2025 Figure 16. Europe Medical Sevoflurane Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Medical Sevoflurane Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Medical Sevoflurane Sales Market Share in Value by Type in 2025 Figure 19. Latin America Medical Sevoflurane Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Medical Sevoflurane Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Medical Sevoflurane Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Medical Sevoflurane Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Medical Sevoflurane Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Children Image Figure 26. Global Children Sales YoY Growth (2021-2032) & (K Units) Figure 27. Adults Image Figure 28. Global Adults Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Medical Sevoflurane Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Medical Sevoflurane Market Share by Application 2025 VS 2032 Figure 31. North America Medical Sevoflurane Sales Market Share in Volume by Application in 2025 Figure 32. North America Medical Sevoflurane Sales Market Share in Value by Application in 2025 Figure 33. Europe Medical Sevoflurane Sales Market Share in Volume by Application in 2025 Figure 34. Europe Medical Sevoflurane Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Medical Sevoflurane Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Medical Sevoflurane Sales Market Share in Value by Application in 2025 Figure 37. Latin America Medical Sevoflurane Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Medical Sevoflurane Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Medical Sevoflurane Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Medical Sevoflurane Sales Market Share in Value by Application in 2025 Figure 41. North America Medical Sevoflurane Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Medical Sevoflurane Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Medical Sevoflurane Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Medical Sevoflurane Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Medical Sevoflurane Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Medical Sevoflurane Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Medical Sevoflurane Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Medical Sevoflurane Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Medical Sevoflurane Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Medical Sevoflurane Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Medical Sevoflurane Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Medical Sevoflurane Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Medical Sevoflurane Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Medical Sevoflurane Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Medical Sevoflurane Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Medical Sevoflurane Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Medical Sevoflurane Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Medical Sevoflurane Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Medical Sevoflurane Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Medical Sevoflurane Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Medical Sevoflurane Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Medical Sevoflurane Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 250ml/Bottle
  • 120ml/Bottle
  • Other
Applications
  • Children
  • Adults
Companies covered
  • AbbVie
  • Maruishi
  • Piramal
  • PT Novell Pharmaceutical
  • Viatris
  • Baxter
  • Lunan Pharma
  • Hengrui

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Medical Sevoflurane Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Medical Sevoflurane Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Medical Sevoflurane Market by Type
  6. 1.3.1 250ml/Bottle
  7. 1.3.2 120ml/Bottle
  8. 1.3.3 Other
  9. 1.4 Global Medical Sevoflurane Market Size by Type
  10. 1.4.1 Global Medical Sevoflurane Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Medical Sevoflurane Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Medical Sevoflurane Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Medical Sevoflurane Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Medical Sevoflurane Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Medical Sevoflurane Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Medical Sevoflurane Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Medical Sevoflurane Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Medical Sevoflurane Industry Trends
  2. 2.2 Medical Sevoflurane Industry Drivers
  3. 2.3 Medical Sevoflurane Industry Opportunities and Challenges
  4. 2.4 Medical Sevoflurane Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Medical Sevoflurane Revenue (2021-2026)
  2. 3.2 Global Top Players by Medical Sevoflurane Sales (2021-2026)
  3. 3.3 Global Top Players by Medical Sevoflurane Price (2021-2026)
  4. 3.4 Global Medical Sevoflurane Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Medical Sevoflurane Major Company Production Sites & Headquarters
  6. 3.6 Global Medical Sevoflurane Company, Product Type & Application
  7. 3.7 Global Medical Sevoflurane Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Medical Sevoflurane Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Medical Sevoflurane Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Medical Sevoflurane Tier 1, Tier 2, and Tier 3
4 Medical Sevoflurane Regional Status and Outlook
  1. 4.1 Global Medical Sevoflurane Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Medical Sevoflurane Historic Market Size by Region
  3. 4.2.1 Global Medical Sevoflurane Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Medical Sevoflurane Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Medical Sevoflurane Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Medical Sevoflurane Forecasted Market Size by Region
  7. 4.3.1 Global Medical Sevoflurane Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Medical Sevoflurane Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Medical Sevoflurane Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Medical Sevoflurane by Application
  1. 5.1 Medical Sevoflurane Market by Application
  2. 5.1.1 Children
  3. 5.1.2 Adults
  4. 5.2 Global Medical Sevoflurane Market Size by Application
  5. 5.2.1 Global Medical Sevoflurane Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Medical Sevoflurane Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Medical Sevoflurane Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Medical Sevoflurane Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Medical Sevoflurane Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Medical Sevoflurane Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Medical Sevoflurane Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Medical Sevoflurane Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 AbbVie
  2. 6.1.1 AbbVie Company Information
  3. 6.1.2 AbbVie Business Overview
  4. 6.1.3 AbbVie Medical Sevoflurane Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 AbbVie Medical Sevoflurane Product Portfolio
  6. 6.1.5 AbbVie Recent Developments
  7. 6.2 Maruishi
  8. 6.2.1 Maruishi Company Information
  9. 6.2.2 Maruishi Business Overview
  10. 6.2.3 Maruishi Medical Sevoflurane Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Maruishi Medical Sevoflurane Product Portfolio
  12. 6.2.5 Maruishi Recent Developments
  13. 6.3 Piramal
  14. 6.3.1 Piramal Company Information
  15. 6.3.2 Piramal Business Overview
  16. 6.3.3 Piramal Medical Sevoflurane Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Piramal Medical Sevoflurane Product Portfolio
  18. 6.3.5 Piramal Recent Developments
  19. 6.4 PT Novell Pharmaceutical
  20. 6.4.1 PT Novell Pharmaceutical Company Information
  21. 6.4.2 PT Novell Pharmaceutical Business Overview
  22. 6.4.3 PT Novell Pharmaceutical Medical Sevoflurane Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 PT Novell Pharmaceutical Medical Sevoflurane Product Portfolio
  24. 6.4.5 PT Novell Pharmaceutical Recent Developments
  25. 6.5 Viatris
  26. 6.5.1 Viatris Company Information
  27. 6.5.2 Viatris Business Overview
  28. 6.5.3 Viatris Medical Sevoflurane Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Viatris Medical Sevoflurane Product Portfolio
  30. 6.5.5 Viatris Recent Developments
  31. 6.6 Baxter
  32. 6.6.1 Baxter Company Information
  33. 6.6.2 Baxter Business Overview
  34. 6.6.3 Baxter Medical Sevoflurane Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Baxter Medical Sevoflurane Product Portfolio
  36. 6.6.5 Baxter Recent Developments
  37. 6.7 Lunan Pharma
  38. 6.7.1 Lunan Pharma Company Information
  39. 6.7.2 Lunan Pharma Business Overview
  40. 6.7.3 Lunan Pharma Medical Sevoflurane Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Lunan Pharma Medical Sevoflurane Product Portfolio
  42. 6.7.5 Lunan Pharma Recent Developments
  43. 6.8 Hengrui
  44. 6.8.1 Hengrui Company Information
  45. 6.8.2 Hengrui Business Overview
  46. 6.8.3 Hengrui Medical Sevoflurane Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Hengrui Medical Sevoflurane Product Portfolio
  48. 6.8.5 Hengrui Recent Developments
7 North America by Country
  1. 7.1 North America Medical Sevoflurane Sales by Country
  2. 7.1.1 North America Medical Sevoflurane Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Medical Sevoflurane Sales by Country (2021-2026)
  4. 7.1.3 North America Medical Sevoflurane Sales Forecast by Country (2027-2032)
  5. 7.2 North America Medical Sevoflurane Market Size by Country
  6. 7.2.1 North America Medical Sevoflurane Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Medical Sevoflurane Market Size by Country (2021-2026)
  8. 7.2.3 North America Medical Sevoflurane Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Medical Sevoflurane Sales by Country
  2. 8.1.1 Europe Medical Sevoflurane Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Medical Sevoflurane Sales by Country (2021-2026)
  4. 8.1.3 Europe Medical Sevoflurane Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Medical Sevoflurane Market Size by Country
  6. 8.2.1 Europe Medical Sevoflurane Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Medical Sevoflurane Market Size by Country (2021-2026)
  8. 8.2.3 Europe Medical Sevoflurane Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Medical Sevoflurane Sales by Country
  2. 9.1.1 Asia-Pacific Medical Sevoflurane Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Medical Sevoflurane Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Medical Sevoflurane Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Medical Sevoflurane Market Size by Country
  6. 9.2.1 Asia-Pacific Medical Sevoflurane Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Medical Sevoflurane Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Medical Sevoflurane Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Medical Sevoflurane Sales by Country
  2. 10.1.1 South America Medical Sevoflurane Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Medical Sevoflurane Sales by Country (2021-2026)
  4. 10.1.3 South America Medical Sevoflurane Sales Forecast by Country (2027-2032)
  5. 10.2 South America Medical Sevoflurane Market Size by Country
  6. 10.2.1 South America Medical Sevoflurane Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Medical Sevoflurane Market Size by Country (2021-2026)
  8. 10.2.3 South America Medical Sevoflurane Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Medical Sevoflurane Sales by Country
  2. 11.1.1 Middle East and Africa Medical Sevoflurane Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Medical Sevoflurane Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Medical Sevoflurane Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Medical Sevoflurane Market Size by Country
  6. 11.2.1 Middle East and Africa Medical Sevoflurane Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Medical Sevoflurane Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Medical Sevoflurane Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Medical Sevoflurane Value Chain Analysis
  2. 12.1.1 Medical Sevoflurane Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Medical Sevoflurane Production Mode & Process
  7. 12.2 Medical Sevoflurane Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Medical Sevoflurane Distributors
  10. 12.2.3 Medical Sevoflurane Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst